Yes. APONTIS is owned by private equity investor Paragon Partners.
APONTIS is headquartered in Monheim am Rhein, Germany.
APONTIS has 200 employees.
APONTIS is a life science company.
APONTIS was founded in 2016.
Rolf-Schwarz-Schutte-Platz 1,
Monheim am Rhein,
40789
Germany,
+49 2173 48 4949
www.apontis-pharma.de
APONTIS is a supplier of pharmaceuticals for chronically ill patients. Next to co-marketing activities, the company focuses on the development and promotion of single pills and has established itself as a pioneer in this segment. Single pills are a combination of two to three ingredients in one single pill, which has proven to significantly increase adherence and thus patient prognoses compared to the conventional therapy with 2-3 separate pills. APONTIS was founded in 2016 and is based in Monheim, Germany.
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
